Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Gold you certainly opened Pandora's box on your last statement, "The problem with Constab's technology is the stability of the antibody/anti cancer agent that they are using. It has to be admnistered within two hours of formulation.
The question I would ask of Moro would be concerning the stability of his anti cancer agent. Without the ability to have a significant shelf life, just like Constab, no pharma is going to license it".
VERY INTERESTING!!!! You obviously did not or chose not to really pay attention to the patent and newest discovery. OK, Here are the bullet points again:
>This peptide opens a wide range of possibilities for delivering killing agents to cancer cells
>The synthetic peptide will allow BioCurex to replace the antibodies in the RECAF test
>Peptides are produced with an automated peptide synthesizer
>Peptide is synthesized chemically by special computer software, cost reduction is significant, more stable, resulting in longer shelf life
>To modify a peptide, all that is required is to use a different amino acid sequence on the computer, opens many possibilities for BioCurex
Anyone know how long it takes to secure the patent?
Here's an upcoming meeting this month for Dr Moro or the ghost of Dr Burger: EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics.
It sounds exactly where you should be, no?
I reread the patent application and suggest those that still own shares do the same. I have to agree with Dr Moro that this is a very significant discovery.
1)Dr Moro created a synthetic peptide that recognizes RECAF
2)Air tight worldwide patent includes 142 countries
3)BioCurex's patent application contains over 50 claims covering different applications and uses of this peptide
4)will improve everything we do while reducing the complexity and cost of the process
5)extend the life of our current patents by two decades
6)this peptide opens a wide range of possibilities for delivering killing agents to cancer cells
7)The synthetic peptide will allow BioCurex to replace the antibodies in the RECAF test
8)Peptides are produced with an automated peptide synthesizer
9)peptide is synthesized chemically by special computer software, cost reduction is significant, more stable, resulting in longer shelf life
10)to modify a peptide, all that is required is to use a different amino acid sequence on the computer, opens many possibilities for BioCurex
Bottom line, it is most definitely significant, but can he make money from his years of work on this discovery. IMO it appears as if Dr Moro has done it. He has found a way for therapeutic cancer killing agents to directly find, attach or enter specifically cancer cells without affecting normal healthy cells. My thoughts are that pharmaceutical agents could be used in conjuction with stem cells.
I never doubted Dr Moro's scientific skills just business skills. I guess step one is secure the patent, which I have no idea how long it will take, and step two would be to contact every biotech company on the planet and let them test out this discovery with their drugs.
Kudos Dr Moro. Congratulations. Now can you work on capitalizing on this huge breakthrough, please. I have to admit I fell alot better about the prospects for this company.
Gaboy, there is progress being made. It is significant ONLY IF IT WORTH MORE THAN THE PRESS RELEASE and triggers royalty payments or revenue. I am no longer singing the praises of Dr Moro since I've seen my investment dwindle down to pennies. I am not siding with Goldseeker. Everyone knows what time it is with him. I am not bashing their progress with recaf either, only that they have either blown opportunities, are greedy in their negotiations, or they can't close a deal. It is what it is. I'm only conveying the obvious. I don't understand WHY there are no new licensees, only see that there AREN'T. Who else is to blame? I have multiple other investments in stem cells and other biotech companies which all received tax free dollars from the US government. Most got a million dollars.
Is it game over? Not by a longshot. I am just frustrated that's all. I have every right to be. I want to believe they will succeed, but something significant MUST happen.
Goldseeker, I am not trying to bash my own investment. I am giving them my perspective. They have made accomplishments, but if they don't materialize it means nothing for investors.
Mata, if it is so wonderful, why:
1)are we at a 52 week low?
2)has management not signed any new licensees?
3)is revenue nonexistent?
4)no communication with shareholders?
5)no publications in medical journals?
6)no compulsion for either Dr Moro or Dr Burger to speak to the medical community at any oncology conferences other than the ISOBM?
7)no federal grant money? (I understand this is a Canadian company)
8)nothing heard from Abbott or Inverness?
9)NO 510K OR APPLICATION FOR FDA APPROVAL?
10)NOT USED CLINICALLY?
11)WHY ISN'T MANAGEMENT BUYING SHARES?
It's been almost 7 years and this stock wiped out about 99% of my investment. Yes, I am skeptical. Wouldn't you be? I realize it takes time, but after money was raised under the most dire circumstances, and shareholders basically gave this company a second life, it was pissed away on the most wasteful way possible.....more penny newsletters. Mistakes are mistakes, but when you keep making the same ones it is no longer a mistake it is incompetence.
It's time to show us something that will translate into revenue or this is like a charitable contribution for academic purposes. I will give praise when it translates into revenue. Something is just not right if it is taking this long. Maybe Dr Burger was not the right choice.
Also, if you can prove there is manipulation, why is nothing being done? Wouldn't they have to cover which would force them to buy and cause the share price to rise precipitously?
All the advances are wonderful, and obviously you are all excited at the lab, but in the real world it means nothing to investors unless it translates into creating AND DELIVERING a revenue stream. Apple could have made the Iphone, Ipod, and Ipad and if they sat in their warehouses without being able to sell it would investors be singing their praises? That's how I feel and I'm sure that the few that are remaining share my sentiment. I am waiting for a new licensee, to hear something from Abbott or Inverness, and/or to see the application for FDA approval, otherwise, this is just more of the same.
I'd like to hear something from management that has been nonexistent since they raised the cash.
Interesting press release. Will this translate into a collaboration with a major pharma or is this more of the same? Sorry to say that being at a 52 week low isn't too inspiring as an investor. Surprise me. Please show me that this is not just a dream and will actually make it into the clinic.
Will Alere be paying their royalty payment this month?
FDA application. Nothing else matters.
I used to be emotional over this stock, and have learned a valuable lesson. Time will tell if he delivers on his promises, but I see all my other investments rebounded nicely and many have hit all time highs, but this is the laggard. There is a solution to the problem, and it is to work on getting the product approved, so we'll see his next move. He needs to think about tax time coming up, so he better something to reassure his investors.
It's going to happen and this stock will bounce and catch everyone off guard. I remember when he signed Abbott. It moved quite a bit, and again, no one expected Inverness. He needs to do the hat trick. It does always come when no is expecting it. It is a problem now because he has been taunting us with him saying he is in "negotiations". Well, close the deal.
One of his biggest blunders was his last paid advertisement. I can't let go of that one. I really don't know any CEO that would have signed off on that. For me, that was when I started re-evaluating what I was invested in. He actually swayed investors away and it caused more questions as well as lowered the share price. I don't see any effort by Burger to attend any financial investor conferences. Maybe there is some top secret things happening, but until I see management step in and by stock or see any substantial movement in volume upward I have to assume we are going nowhere. This is a forum to speak about the company and I never held back, and when they surprise everyone with something concrete I'll be back on board. For now I am greatly disappointed.
It is a bit uncanny that since I have been critical of management I have been able to express myself freely, but when I was singing their praises or defending them I was restricted. When the stock is sitting at .05 it's hard to be giddy about that.
I believe Dr Moro will take a step back and make it possible to run the trials realizing that it's showtime. It's like training for years for the Olympics and you have a chance for gold, but you keep finding excuses not to go for it. Dr Moro the gold is in your grasp you just have to reach for it. You have what it takes, so prove it to the FDA. I'm supporting you and I promise all of your shareholders want you to succeed.
If you think that Oncopet will bring in substantial revenue to pay for the trial to avoid further dilution, let us know, otherwise I think you are stalling and you will destroy what little equity is left.
What's the future look like without either a new license or FDA approval. He hasn't done either that is why this is a .05 stock.
It's not Goldseeker that scares me. It's the share price. By the way, Dr Moro almost lost everything. The entire IP and patents were collateral for the Smithline loan thanks to Wittenberg's brilliant negotiations, so no, Dr Moro couldn't have sold sheet. He would have had nothing to sell. If he gets FDA approval he has a viable product. Do you disagree? Wouldn't he instill confidence? Wouldn't the share price respond positively? Wouldn't he save lives? It has nothing to do with Goldseeker and everything to do with management.
Half, I really have no idea. I know he did not license it, but he never explained why. Why can't he close a deal? Over and over we hear he is in negotiations. I have my own theories, but it would be nice to know why he decided to go it alone.
The more you say, the more evident you are. It will kill you to see us first apply to the FDA, and God forbid when he actually gets the approval, then what? Will you say it won't sell? Let me think about that one for awhile. Of course, you would.
Let me sum it up for you:
1)He will apply to the FDA
2)He will receive approval
3)He will have a blockbuster on his hands
4)He will buy investorshub and you will be out of work (Lol)
I completely disagree. You're motives have been well known for quite some time so I don't think what you have to say is in the best interest of shareholders. There is nothing that he will ever do that will be as important as getting thru the FDA hurdle. In all his years of research and discoveries he will have something that is viable and potentially worth millions, but right now it remains to be just a bottle of reagants if he does nothing. I guarantee he WILL do it. He doesn't want to be remembered as a failure, and shareholders won't believe another word he says if he fails to deliver. That being me, and I was his biggest fan for years. Watch and learn.
Gold trying to stir the pot again? Funny.
Dr Moro is constantly changing his plans as evidenced by going direct w/ oncopet. IMO he re-evaluates his prospects and he will realize he has been foolish not to have pursued FDA approval sooner. We certainly wouldn't be sitting at a 52 wk low and probably be at new highs. The longer he postpones the inevitable the closer he is to bankrupting the company. He came to the edge once and and most people would never let it happen again. He can't blame anyone else if he fails, so I am willing to bet he does apply.
Point in fact Gold, you have been wrong more often than right which is quite consoling right now.
I don't want to debate anything with anybody. I am here to wake up Dr Moro that is focused on the science and obviously not on making shareholders a profit. If I don't hear anything in the near future I will have to rethink my position here.
It seems like the information that Mata has provided is so detailed I really don't think anyone could make up such a claim, however, I just don't understand how shorting the stock backed by warrants is yielding funds that according to Mata are needed by a fledgling mining company. Wouldn't this show up on their balance sheet in their 10Q? If so, it would be incriminating evidence.
Gold, I must say it is peculiar that you adamantly refuse to accept that in all likelihood someone is intentionally manipulating the share price. To me, it is evident just looking at the daily trading patterns.
Dr Moro has always been confident about the technology, so there should be no reason for him not to put in the application with the FDA. Just the application alone will generate excitement and send a clear message to shareholders and those shorting.
If there truly is naked shorting going on, they would be instantly bitch-slapped if you applied for FDA approval. We've been told over and over again by Mata that millions of share are being shorted backed by warrants, but in essence they are betting against you EVER getting FDA approval. So far they have been correct. I have bet on you and I have been wrong. I don't like being wrong.
Duke, I am putting management to the fire and will continue to do so until they come to the realization that they are destroying whatever shareholder equity is left by failing to get recaf approved for "something". Why are they basically holding onto years of research, but willing to throw substantial amounts of money out the window year after year to "advertise" the company which has done more damage and attracted the worst kind of daytraders to the stock.
At this point, I will be the first to congratulate Dr Moro and apologize for my disparaging remarks if he is working behind the scenes getting all of his ducks in a row in anticipation of applying to the FDA. If he isn't, I will be relentless in my pursuit to get the sand out of his eyes, and make him aware that this stock has lost 99% of its value since the high in 2004. It's been painful to watch the equity markets return to normal levels and this stock which has no liquidity, has only further deteriorated.
I guess we'll never know if recaf could have saved human lives or caught cancer early since there seems to be no rush to get recaf approved. Shameful. What a pity.
FDA approval, FDA approval, FDA approval! Everyone say it with me.....FDA APPROVAL!!!!!!
Nothing else matters to investors. Either you have the goods or you don't.
FDA approval, FDA approval, FDA approval! Everyone say it with me.....FDA APPROVAL!!!!!!
Nothing else matters to investors.
When are you going to get FDA approval? Dr Moro, I certainly don't think this was your vision for the company and the future of recaf. Maybe you will surprise investors with incredible revenues from oncopet, but the future of this company depends on getting recaf approved for HUMANS.
It's time to capitalize on years of research and years of collecting data and take this company to the next level.
Do I need to remind you what happened when you said that recaf was FDA approved? The stock shot up from a level we are today to several dollars overnight. Why? BECAUSE YOU SAID IT WAS FDA APPROVED? Isn't it ironic that after 6 years you still fail to realize why the share price is at 5 cents, and the reason is you DON"T have FDA approval. Your failure to act has caused this stock to lose 99% of its value since that overnight pop. Just filing for FDA approval you would see this stock jump to a new 52 week high, AND send a message to those shorting that this will be a profitable company.
I think you need to see things from an outsider, and someone that has something at stake that WANTS you to succeed.
#1 immediate goal has to be FDA approval. This is the one thing investors would see as a GIANT step forward. Doesn't that make much more sense than PAYING for a report that won't even recommend buying shares in the company? It is evident that no one is buying into oncopet until we see revenue, however, getting FDA approval would the most significant achievement in the history of this company. You have an opportunity to fulfill a promise, and enhance credibility and confidence. It's a must.
Dr Moro, you can't sell an unapproved product. Are you EVER going to get FDA approval or you going to continue experimenting? For a company that claims to have had several opportunities to partner and seize upon revenue, why have you failed to capitalize? After nearly bankrupting the company, haven't any lessons been learned?
Dr Moro WHEN?
According to the website slide presentation, management gave themselves 18 months from 1/1/2010. We must see FDA trials NOW. YOU CANNOT SELL A TEST THAT HAS NOT BEEN FDA APPROVED!!!! There seems to be a lack of direction. Every press release sends a different message. They were supposed to license oncopet, and now without a full explanation he decided to self market and go it alone. IMO all the energy and dollars should have been focused on getting an FDA approval for recaf. Failure to do so is like going to medical school and not passing the board exams. You cannot practice without a license. You have a product that cannot be sold. What are you waiting for? I thought lessons were learned after the near collapse of the company, but we seem to be backpeddling again. Spend the money shareholders approved on what you said you were going to use the money for....FDA approval. Then shareholders will at least feel that recaf has a future, otherwise this was a big mistake for me. It is usually the other way around where a biotech company jumps the gun too early and fails trials. Dr Moro you know you have adequate data to present to the FDA, so I really am getting upset that you don't seem too concerned that the share price is at this level because you are not proceeding with trials. I have every right to express my concerns after being patient for 6 years. You also have no projections for oncopet. Why? I don't give a sheet in Goldseeker's response. I'd like to hear from you!
FIVE catalysts that will move this stock
1)positive earnings
2)new licensee
3)insider buying
4)company is bought out
5)pulished data in a well regarded medical journal
I personally feel that insider buying reflects good things to come and it would make me feel much better to see all those that have failed to deliver finally put some skin in the game. It is unfair that everyone at Biocurex has nothing monetarily to lose (potential earnings lost is bullsheet).
This re-launch IMO is peculiar. There is no update anywhere on the collection of new data they make reference to in the pr, so what and where is this new information on the data that requires a relaunch and will drive new sales?
I have been negative for quite some time which may seem counterintuitive to my investment and being a large shareholder, but why can't Dr Moro or Burger close a deal. IMO it has the appearance of him being too greedy or uncreative in his negotiations. There are endless ways to close a deal, but someone there is either unconvincing or just poor at negotiations. If they came to Biocurex they were interested and either Berger or Moro LET THEM WALK. How is this ever going to become the company Dr Moro and Dr Burger speaks of if they let their potential licensees walk away from the table? I just hope their inability to close a deal will end before some new technology comes along, they run out of money, or the patents expire. We must see one of those 5 catalysts I mentioned, otherwise we are going nowhere. The market conditions are absolutely no longer an excuse. Can someone from Biocurex please follow up on the press release as to why he feels he must relaunch oncopet. What was the new data?
FDA aproval, FDA approval, FDA approval????
That is the foremost important question, and now I have realized after more than 6 years it should have been the deciding factor in committing all that money to this company.
You can't have significant revenue without the FDA approving the product to sell. This should have been Dr Moro's number goal. This is a kin to being the builder and the owner is backed by investors to several beautiful buildings standing tall in desired areas of commercial real estate that are sitting there empty because there, because there are no permits to open the doors. They are built and ready to go, the hard work is done, but the builder for whatever reason is reluctant or stubborn or thinks it is too difficult to follow protocol or he does want to pay the city for the permits, so even though there are potential tenants willing to sign a lease, the buildings that could be generating revenue are worthless, and soon the builder will be forced in bankruptcy. The builder continues to build more buildings while those that could be generating revenue sit idle, so not only is he unwilling to get the permits, but he continues spending to build more. To add to his expenses he spending his last dime on advertising the building that no one can rent with an advertising agency that says nothing positive, but highlights all the negatives, and says if you want to rent we really can't recommend the place, but here is what is wrong with the building.
Do you finally see what I see? Do you get it? Dr Moro you have NOTHING unless you have an approved product. Potential doesn't put money in the bank. I am very successful in business, and I thought by you having a seasoned biotech executive to you help run the company would be the answer, but he seems MIA, and has just become another expense unless he is working on something I don't know about.
You are running out of money, so instead of squandering it, spend it wisely on the FDA approval, and then EVERYTHING will fall into place. Mark my words, you will have a successful product, and you will feel vindicated and respected by your shareholders. That is the only thing that will save this company. Good luck.
Bottomline is share price is where it is, because of management. You can't blame Goldseeker or certainly not the markets. (I am not befriending Goldseeker or agreeing with all of what he says). The pattern has repeated itself over and over. No communication, then a paid advertisement in a penny newsletter or some obscure paid promotional site. You already know how I feel about the last attempt for a paid advertisement. (It actually HURT the share price!!!)
I have a solution for you Dr Moro and the rest of management to regain credibility in a big way. ALL OF YOU have options to purchase shares of BOCX stock. If we saw insider buying I promise all would be forgotten and your trust would be restored. Otherwise, you better come to the realization that another round of funding will not happen. Your other solution is going for the FDA approval. From someone that has waited patiently for 6 plus years, the Koolaid is tasting pretty bitter right now. Being outspoken and one of your greatest advocates it is time for YOU, Dr Moro, to show us, your shareholders, the money. Something must be done to restore faith. I believe you will surprise as you have in the past and come thru, but just letting you know from where I sit the clock is ticking, and the natives are VERY restless. Again, it is a pity to communicate in this way, but I'll do whatever it takes to open your eyes to the facts.
The stock price is at a 52 week low. It is illegal to short warrants, but if you think about it the individuals are shorting because they do not think the share price will go up. So far they were they win and investors lose. IF THERE WAS A REASON FOR THE SHARE PRICE TO RISE the naked shorting would not be an issue. I think it is part of the problem, but IMO it is just an excuse for the share price being so dreadfully low.
Mata, you always start out by saying hello bocxfans, and the sad part is there aren't many bocxfans at .06 a share. I was ready to throw my computer across the room when I saw that last attempt at publicizing the company that was PAID and put a neutral rating on the stock. I'd like to know why this is being paid for.
IMO medicine is being molded towards a point when it WILL BE personalized medicine. I also know that there is stem cell company that has been successful in destroying cancer stem cells. Knowing this and how fast new therapies are emerging in biotech I think that recaf will be useful in monitoring and I am perplexed why Dr Moro fails to get ANY FDA approval for ANY indications recaf could be useful. Is it poor management or does he think someone else will pay for the trials, which IMO is his biggest mistake of all? I can't figure out how he thinks shareholders will continue to support the company without getting the necessary approvals to sell the test. Just explain this please. The noise here is just noise, although occassionally there is one nugget of valuable information from time to time. If Half wants to continue battling on behalf of the company that's his perogative. I personally think it is time for Dr Moro to pull back the curtain and expalin why there are delays or what his future plans are. It is also sad that a very large shareholder is communicating to the company in this way. (I have called and left messages).
****http://www.sfc.hk/sfcPressRelease/EN/sfcOpenDocServlet?docno=10PR40
http://www.quamnet.com/learninglist.action?listSectionCode=LRN_WRT
http://www.tradingresource.com/content/articles/Short-Selling-Strategies.html
I have to say something else. This investment no longer becomes an investment when management allows the law to be broken and destroy shareholder's equity. If nothing is done, I no longer have faith or trust in this company, so pointing it out only infuriates me. I was one the company's greatest allies for many years, but it is management's legal responsibilty to protect its shareholders and put an end to the naked shorting. If money is at issue, you should have thought about that when hiring a pr firm to say that they are neutral on the stock. That was pathetic. I believe in the technology or surely would not be here.
Mata, to you this must be fun, but I have to tell you it hasn't been fun as an investor. What is the point in your posts if not a damn thing is being done about it?
What is being done about the shorting? What happened at the ISOBM. What is happening with FDA trial for approval? What is happening with dogrecaf sales? What is happening with POC tests? What is happening in general?
ISOBM ended. Time for an update.
Mata, tell me what good is this information if management can't or will do nothing about it. The stock is easily shorted when there hasn't been any concrete news. Give those scumbags a reason to be scared. We need to hear that the SEC, the FBI, or the Dept of Justice has stepped in and put an end to the manipulation, or more importantly we hear some positive news in regards to the future of the company and revenues. From an investor's point of view it looks to me like there was alot of backroom deals with shady characters that put us in this mess and have kept us there. You can't be a profitable company with no revenues, so why hasn't FDA approval been a priority? You have a precedent (onkosure), you have the funds, you have access to samples, you have a lab, you have skilled lab technicians, so why would this not be management's #1 priority. You have patents, all the technology has been presented at the ISOBM. There are no secrets that can be stolen, so why has Dr Moro been so reluctant to get the essential FDA approval? I just don't get it!
Mata, first Goldseeker is absolutely correct in questioning the naked shorting. I have no reason to believe this either UNLESS I SEE A PRESS RELEASE or definitive proof the SEC has been contacted. 3.500.000 shares FORCED TO COVER would bring a massive surge in the share price since the volume is so anemic in this stock.
Second, as far as the last "advertisement" of BOCX, I thought to myself that the only way the neutral rating made any sense whatsoever would be if there was concrete substantial news on the horizon where this "advertisement" becomes an endorsement, and they change their recommendation to a buy. A risky tactic and means nothing unless it is something where we will see any revenue in the near future. If that is not the case, then management's PR skills really need to be called into question to squander capital that was raised that caused a great amount of dilution to loyal shareholders. Alot of great progress in the recaf technology has kept us invested, and we (shareholders) need to see at least some of the promises fulfilled. The best step forward would be moving toward the FDA approval.
So Mata, if you now know with certainty who, how, and when, what the f is management doing about it? Are they not involving the authorities? For me personally, if management does nothing it is as bad as co-conspiring, because they saw a crime and did nothing. I assume that is not the case, and they HAVE notified the authorities. As far as the future share price, unless they sign another licensing deal or more importantly get FDA approval, this stock can't get any traction. Remember Dr Moro saying he wants the quickest route to revenue. He at least understand that. He just has to make it happen. Do you not think that it would have made better sense to hire outside reps to promote Doggyrecaf instead of the thousands spent on that tepid advertisement? I would certainly not call it an endorsement! Yes, I am frustrated.
Mata, now that the source of the illegal manipulation is factually known, what is management going to do about it? If true, these thieves have stolen from me and many other shareholders. As far as I am concerned MANAGEMENT NOW HAS A RESPONSIBILTY TO ITS SHAREHOLDERS TO PROSECUTE THESE INDIVIDUALS. If a crime is being committed and you have the information, it is an obligation under the law to bring this to justice. I expect to see a press release that the SEC and the FBI are prosecuting these individuals and an indictment has been issued. If Dr Moro or Dr Berger have funds for a tepid endorsement that was paid to solicit new investors which issues a neutral opinion (are you kidding me?), then they have the resources to protect their shareholders. Did Dr Moro really sign off on a neutral endorsement? Was this what he signed up for? Was he pleased with his investment? I've never seen anything like it in my life. They would have been better off just presenting the facts and saying they don't make buy or sell recommendations.
I can't put in words how upsetting it is to see management continue to throw our limited resources away on paid advertisements. After being a supportive shareholder of the science for years, I have to say IMO it is the single most frustrating and wasteful source of funds with no ROI whatsoever. I don't know why Dr Berger is not presenting at more investor conferences? After advancing the science over the last 3 years since adding Inverness as a licensee, I would hope to see a new partner emerge this year.
Management has set forth their goals for this year, and I have my own set of goals for management for the balance of this year and into the next.
1)Prosecute the illegal stock manipulators IMMEDIATELY
2)Stop throwing money out the window on paid daytrader newsletters
3)Dr Berger present at more investment conferences
4)Dr Moro present the science at more oncology meetings
5)Publish our technological breakthroughs in scientific journals
6)Achieve FDA approval (otherwise nothing to sell=no revenue)
7)Sign a new licensee
8)Collect licensing fees from current licensees
I won't say much more on this, but I'll be watching.
Mata, you are the only reason why I even check this board. Thanks for your important contributions. (I see that yahoo finance has a message board for BOCX fans as well). It appears good things seem to be happening, so I will continue to be patient. No one is selling except the illusion can be created by those lowlife manipulators. This year is pivotal to the future of Biocurex. I assume data is being collected to present to the FDA as sighted on the BOCX website as one of the company's main objectives. FDA approval IMO should precede another licensing agreement unless that licensee is flipping the bill. They need to have a product to launch and that should have always been their #1 focus. Otherwise the licensees are there to sell what? They are the marketers and distributors. No one makes money w/o a product. Now that management realizes monitoring is their best shot I hope they are working feverishly collecting sufficient data to move forward with the 510k. After monitoring is approved THEN move forward with FDA approval on POC device. The POC device should be in development now, and should be ready to roll just after the monitoring application is approved to get the product out into the medical field. This year is presently over half over and I'm sure investors would love to see an application with the FDA soon.
I figured you out Mr goldseeker. I now know how you have been able to do what you have been doing for so long and getting away with it. Clever, but really not that clever as you will find out. I will make a call to Biocurex and let them know what I was I was able to deduce from today's events.